Las Vegas, Nev. From the Microsurgery and Hyperbaric Laboratory, Division of Plastic Surgery, Department of Surgery, University of Nevada School of Medicine.
Plast Reconstr Surg. 2010 Aug;126(2):403-411. doi: 10.1097/PRS.0b013e3181df64a5.
Hyperbaric oxygen decreases ischemia-reperfusion-induced neutrophil/intercellular adhesion molecule-1 adhesion by blocking CD18 polarization. The purpose of this study was to evaluate whether this hyperbaric oxygen effect is nitric oxide dependent and to determine whether nitric oxide synthase is required.
A gracilis muscle flap was raised in nine groups of male Wistar rats. Global ischemic injury was induced by clamping the gracilis muscle pedicle artery and vein for 4 hours. The hyperbaric oxygen treatment consisted of 100% oxygen at 2.5 atm absolute during the last 90 minutes of ischemia. Groups were repeated with and without various nitric oxide synthase inhibitors and carboxy-2-phenyl-4,4,5,5,-tetramethylimidazoline-1-oxyl-3-oxide (C-PTIO), a nitric oxide scavenger. Normal neutrophils were exposed to activated plasma on intercellular adhesion molecule-1-coated coverslips (percentage adherent) and labeled with fluorescein isothiocyanate/antirat-CD11b for confocal microscopy (percentage polarized). The percentage of adherent and polarized cells was reported as mean + or - SEM. Statistical analysis was by analysis of variance. A value of p < or = 0.05 was considered significant.
C-PTIO-treated ischemia-reperfusion/hyperbaric oxygen plasma showed a significant increase in the percentage polarization of CD18 compared with ischemia-reperfusion/hyperbaric oxygen-untreated plasma from 4.1 + or - 2.5 percent to 33.7 + or - 7.7 percent (p < or = 0.05). The nitric oxide scavenger C-PTIO also increased the percentage of adherent cells from 1.6 + or - 0.4 percent to 20.3 + or - 5.9 percent (p < or = 0.05). Administration of N-nitro-L-arginine methyl ester and other nitric oxide synthase inhibitors before hyperbaric oxygen treatment restored neutrophil adhesion and CD18 polarization to ischemia-reperfusion control values, significantly greater than ischemia-reperfusion/hyperbaric oxygen alone.
These results suggest that the hyperbaric oxygen reduction of ischemia-reperfusion-induced neutrophil polarization of CD18 and adherence to intercellular adhesion molecule-1 is mediated through a nitric oxide mechanism that requires nitric oxide synthase.
高压氧通过阻断 CD18 极化来减少缺血再灌注诱导的中性粒细胞/细胞间黏附分子-1 黏附。本研究的目的是评估这种高压氧作用是否依赖于一氧化氮,并确定是否需要一氧化氮合酶。
在 9 组雄性 Wistar 大鼠中制备了一块比目鱼肌皮瓣。通过夹闭比目鱼肌蒂动静脉 4 小时诱导全局缺血损伤。高压氧治疗包括在缺血的最后 90 分钟内用 2.5 绝对大气压的 100%氧气。重复进行了有和没有各种一氧化氮合酶抑制剂和羧基-2-苯基-4,4,5,5,-四甲基咪唑啉-1-氧-3-氧化物(C-PTIO),一种一氧化氮清除剂的处理。将激活的血浆暴露于细胞间黏附分子-1 涂覆的盖玻片上的正常中性粒细胞(黏附百分比),并用异硫氰酸荧光素/抗大鼠-CD11b 进行共聚焦显微镜(极化百分比)标记。黏附细胞和极化细胞的百分比报告为平均值+或- SEM。统计分析采用方差分析。p 值≤0.05 被认为具有统计学意义。
与缺血再灌注/高压氧未处理的血浆相比,C-PTIO 处理的缺血再灌注/高压氧血浆中 CD18 的极化百分比显著增加,从 4.1+或-2.5%增加到 33.7+或-7.7%(p≤0.05)。一氧化氮清除剂 C-PTIO 还将黏附细胞的百分比从 1.6+或-0.4%增加到 20.3+或-5.9%(p≤0.05)。在高压氧治疗前给予 N-硝基-L-精氨酸甲酯和其他一氧化氮合酶抑制剂,使中性粒细胞黏附和 CD18 极化恢复到缺血再灌注对照值,明显大于单独缺血再灌注/高压氧。
这些结果表明,高压氧减少缺血再灌注诱导的中性粒细胞 CD18 极化和细胞间黏附分子-1 黏附是通过一种需要一氧化氮合酶的一氧化氮机制介导的。